Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer

PURPOSE: Changes occur in the expression of oestrogen-regulated and proliferation-associated genes in oestrogen receptor (ER)-positive breast tumours during the menstrual cycle. We investigated if Oncotype® DX recurrence score (RS), Prosigna® (ROR) and EndoPredict® (EP/EPclin) prognostic tests, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Haynes, Ben P., Schuster, Gene, Buus, Richard, Alataki, Anastasia, Ginsburg, Ophira, Quang, Le Hong, Han, Pham Thi, Khoa, Pham Hong, Van Dinh, Nguyen, Van To, Ta, Clemons, Mark, Holcombe, Chris, Osborne, Caroline, Evans, Abigail, Skene, Anthony, Sibbering, Mark, Rogers, Clare, Laws, Siobhan, Noor, Lubna, Cheang, Maggie Chon U., Cleator, Susan J., Smith, Ian E., Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558287/
https://www.ncbi.nlm.nih.gov/pubmed/34524591
http://dx.doi.org/10.1007/s10549-021-06377-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558287/
https://www.ncbi.nlm.nih.gov/pubmed/34524591
http://dx.doi.org/10.1007/s10549-021-06377-3

Ejemplares similares